The donation will fund the company’s clinical and lab-based stem cell research and expand its Regenexx Physician Network. Regenerative Sciences is the maker of Interventional Orthopedics, an injection-based treatment to promote healing of orthopedic injuries and degenerative conditions.
More Articles on Orthopedic Surgery:
20 Spine Devices Receive FDA 510(k) Clearance in May
USC Names Dr. Jay Lieberman Chair of Orthopedic Surgery Department
Orthopedic Surgeons Suffer Second-Largest Compensation Decline in 2010-2011
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
